Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
about
Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failureClinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysisInflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.Non-cystic fibrosis bronchiectasis: review and recent advances.Effect of low-dose, long-term roxithromycin on airway inflammation and remodeling of stable noncystic fibrosis bronchiectasisSpontaneous pneumothorax in the third trimester of pregnancyAssessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index.Persistent sputum cellularity and neutrophils may predict bronchiectasis.Bronchiectasis--diagnosis and treatmentNon-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis BronchiectasisChest pain and exacerbations of bronchiectasis.Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography.Bronchoscopy, Imaging, and Concurrent Diseases in Dogs with Bronchiectasis: (2003-2014).Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study.The role of the high-sensitivity C-reactive protein in patients with stable non-cystic fibrosis bronchiectasis.The pathophysiology of bronchiectasisEmerging drugs for bronchiectasis.Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management.Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis.Defining severity in non-cystic fibrosis bronchiectasis.Emerging drugs for bronchiectasis: an update.Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.Pediatric bronchiectasis: No longer an orphan disease.Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency.Bronchiectasis in yellow nail syndrome.High-flow nasal cannula therapy for adult patients.Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.Molecular identification and genotyping of Pseudomonas aeruginosa isolated from cystic fibrosis and non-cystic fibrosis patients with bronchiectasis.Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis.Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis.Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.Exacerbations in COPD Patients with Bronchiectasis.Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis.Is There a Correlation between New Scoring Systems and Systemic Inflammation in Stable Bronchiectasis?Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis.
P2860
Q26749320-5DDF4446-6F30-424B-9B18-29A13C0202FFQ26801306-2579B5A0-87EE-440A-96E8-000D0AD12698Q33794333-A7380913-118A-4C71-A3B9-9A5F288D469FQ34167368-403AB15F-6E75-49AE-B8DB-8C9B00ED3F3CQ34530078-F9FB4C1D-7073-49C4-AE76-A1663F6CD682Q34534658-F6F8EF21-E7F2-42F0-9777-C775E5112994Q35426582-A54125EB-E795-46D9-90B0-61A353F8FAC7Q35487780-07D3C2A0-C003-438D-A9B1-8BFC8485B901Q35628004-24F3BD30-F429-499E-8152-FACB1CC721A2Q35756143-DB2E1547-D36F-4488-8A82-9EFF33A77115Q35917015-472CB717-AD73-411F-AC26-B137A048FF0CQ36447114-8963A834-5C24-4182-A470-1927D3CC3FEEQ36479483-F15D7CA3-61CF-4D97-B96E-6E6D9E71AEF1Q36777597-8608596F-D9DC-45C4-937B-6B818AA9A6E8Q37020408-4CD4638B-02A5-43B3-A975-73EF30DA40D8Q37364963-D317AAA6-3339-4EBE-8F55-65D70AB3638BQ37409809-48930AB2-4E38-4582-928E-A64F4918754BQ37474543-7C460C30-6D7F-4B3A-AAD6-983E352183E2Q38027233-E9AF2A76-625E-4C2C-8FDC-3FDF24CF3D83Q38078833-3BFC456E-6561-4FAA-9B49-968D51381331Q38089196-D6769592-1100-488C-B8BB-9334BF91C8A8Q38108277-20F58832-C14C-4673-81C9-60AD5E239A2FQ38193861-436F69A6-9A06-435C-8991-617EF66E1D0AQ38367379-E75733AA-5123-4E2D-A53C-348E9D1AC7D5Q38681962-B7D9436B-A8E3-4F69-87E9-9B4B416C70BFQ38721361-9AEB4CA1-84C5-4747-AD71-AD75E465EFB0Q38788006-FE0CC7B9-2931-4A02-BC71-51EEDB3D0A90Q38797806-2F772F47-9885-431B-BF57-0F73A80F23DFQ38875787-38784665-2B59-4CC8-8545-B9B632FC9971Q38934699-F98CEF8C-6132-4A7F-B67D-B5748FAB6D72Q38971318-DC655111-6A72-4F89-ABF7-5ED89E2ECCA1Q41109186-C0FECCED-CCEC-4140-8248-2B8B26B401E5Q41461270-624B5347-FC36-4867-BF56-B1D65C7B2325Q41687136-1CE055BD-BBCD-4B18-ACDF-E963CDD04086Q43565073-E410868D-D0EC-44A3-BED6-0D79AF10100CQ45837740-77BDF475-1DE1-4082-8B18-739183395F04Q47097740-7BA659CA-7B17-45FF-B6AC-C61EE8707956Q47138208-7178891E-839C-4EBE-8E6F-17194BBD5D3DQ47162382-8527EFB9-FEF6-47A7-B503-B67C5BC0A4F0Q48430924-06705EDF-2E0E-4F47-9715-8113535B3617
P2860
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@en
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@nl
type
label
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@en
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@nl
prefLabel
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@en
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@nl
P2093
P1476
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms.
@en
P2093
A De Felice
S Fuschillo
P304
P356
10.1183/09031936.00069007
P577
2008-02-01T00:00:00Z